UK charity slams high rates of late diagnoses of lung cancer
This article was originally published in Clinica
UK cancer charity Macmillan Cancer Relief (MCR) has greeted the latest national mortality statistics with calls for the earlier diagnosis of lung cancer. 80% of lung cancer cases are inoperable due to their late diagnosis, according to the charity. "If people were diagnosed at a much earlier stage, it would be possible for many more of them to have an operation that could potentially cure their cancer," said MCR chief executive Peter Cardy. Cancer of the trachea, bronchus and lung was the third leading cause of death in males (7.5%), and sixth in females (4.5%), in England and Wales in 2005, according to the Office of National Statistics.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.